The acceptor substrate specificity of human beta4-galactosyltransferase V indicates its potential function in O-glycosylation.
Substance Nomenclature: | 0 (DNA, Complementary) 0 (Recombinant Proteins) 9013-90-5 (Lactalbumin) EC 2.4.1.- (Galactosyltransferases) |
---|---|
Entry Date(s): | Date Created: 19990601 Date Completed: 19990624 Latest Revision: 20190621 |
Update Code: | 20240829 |
DOI: | 10.1016/s0014-5793(99)00462-7 |
PMID: | 10350056 |
Autor: | van Die I; Department of Medical Chemistry, Vrije Universiteit, Amsterdam, The Netherlands. im.van_die.medchem@med.vu.nl, van Tetering A, Schiphorst WE, Sato T, Furukawa K, van den Eijnden DH |
Jazyk: | angličtina |
Zdroj: | FEBS letters [FEBS Lett] 1999 Apr 30; Vol. 450 (1-2), pp. 52-6. |
DOI: | 10.1016/s0014-5793(99)00462-7 |
Abstrakt: | In order to assess the function of the different human UDP-Gal:GlcNAc beta4-galactosyltransferases, the cDNAs of two of them, beta4-GalT I and beta4-GalT V, were expressed in the baculovirus/insect cell expression system. The soluble recombinant enzymes produced were purified from the medium and used to determine their in vitro substrate specificities. The specific activity of the recombinant beta4-GalT V was more than 15 times lower than that of beta4-GalT I, using GlcNAc beta-S-pNP as an acceptor. Whereas beta4-GalT I efficiently acts on all substrates having a terminal beta-linked GlcNAc, beta4-GalT V appeared to be far more restricted in acceptor usage. Beta4-GalT V acts with high preference on acceptors that contain the GlcNAc beta1-->6GalNAc structural element, as found in O-linked core 2-, 4- and 6-based glycans, but not on substrates related to V-linked or blood group I-active oligosaccharides. These results suggest that beta4-GalT V may function in the synthesis of lacNAc units on O-linked chains, particularly in tissues which do not express beta4-GalT I, such as brain. |
Databáze: | MEDLINE |
Externí odkaz: |